Related Experiment Video
Updated: Jul 18, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Surgical experience for the pulmonary artery sarcoma.
Ayako Maruo1, Yutaka Okita, Kenji Okada
1Department of Cardiovascular Surgery, Kobe University School of Medicine, Kobe, Hyogo, Japan. ayakom@hbhc.jp
The Annals of Thoracic Surgery
|November 28, 2006
Summary
Pulmonary artery sarcoma is a rare and deadly cancer. Early diagnosis and surgical removal offer the best hope for survival in patients with this condition.
Area of Science:
- Cardiovascular Surgery
- Thoracic Oncology
- Pulmonary Medicine
Background:
- Pulmonary artery sarcoma is an exceptionally rare malignancy.
- The disease carries a poor prognosis.
Purpose of the Study:
- To review surgical outcomes for pulmonary artery sarcoma.
- To identify factors influencing patient survival.
Main Methods:
- Retrospective review of five patients who underwent surgical resection for pulmonary artery sarcoma.
- Analysis of diagnostic accuracy, surgical complications, and long-term outcomes.
Main Results:
- Misdiagnosis as pulmonary embolism was common, occurring in four out of five patients.
- One patient experienced complications related to cardiopulmonary bypass.
- Two patients achieved long-term survival, with one surviving 36 months and another 30 months post-surgery.
Conclusions:
- Prompt diagnosis is critical for improving outcomes in pulmonary artery sarcoma.
- Complete surgical resection is a key therapeutic strategy.
- Multidisciplinary management may enhance patient survival rates.
